Indacaterol/mometasone
combination drug
Indacaterol/mometasone, sold under the brand name Atectura Breezhaler among others, is a fixed-dose combination medication for the treatment of asthma in adults and adolescents twelve years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2 agonists.
The most common side effects include worsening of asthma and nasopharyngitis (inflammation in the nose and throat). Other common side effects include upper respiratory tract infection (nose and throat infections) and headache. Indacaterol/mometasone was approved for medical use in the European Union in May 2020, and in Japan in June 2020.
“Indacaterol/mometasone” enters the record as combination drug. Crown Archives preserves that source wording while asking what Indacaterol, mometasone and combination can confirm, complicate or overturn.
Why this record matters
“Indacaterol/mometasone” is worth following because a concise public description often conceals a longer documentary argument. Here, Indacaterol, mometasone and combination provides the most credible route into that argument.
The citation trail is more important than the brevity of the summary: it shows where individual claims can be examined in context. The source revision retrieved here is dated Oct 8, 2025. The linked authority identifier is Q97355508. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2020.
A concise general-reference account can conceal disagreements about scope, terminology or the weight assigned to individual sources. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Indacaterol/mometasone”, its source revision and the description used here.
- Expand the search: follow Indacaterol/mometasone primary sources, Indacaterol/mometasone archive and Indacaterol research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Indacaterol/mometasone”?
- Which institution is responsible for the underlying evidence?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Indacaterol/mometasone” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.